Advertisement
Canada markets open in 4 hours 47 minutes

  • S&P/TSX

    22,011.62
    +42.38 (+0.19%)
     

  • S&P 500

    5,116.17
    +16.21 (+0.32%)
     

  • DOW

    38,386.09
    +146.43 (+0.38%)
     

  • CAD/USD

    0.7302
    -0.0019 (-0.27%)
     

  • CRUDE OIL

    82.77
    +0.14 (+0.17%)
     

  • Bitcoin CAD

    86,000.88
    -925.06 (-1.06%)
     

  • CMC Crypto 200

    1,311.34
    -27.72 (-2.07%)
     

  • GOLD FUTURES

    2,325.70
    -32.00 (-1.36%)
     

  • RUSSELL 2000

    2,016.03
    +14.03 (+0.70%)
     

  • 10-Yr Bond

    4.6140
    -0.0550 (-1.18%)
     

  • NASDAQ futures

    17,892.75
    -11.50 (-0.06%)
     

  • VOLATILITY

    14.81
    +0.14 (+0.95%)
     

  • FTSE

    8,176.32
    +29.29 (+0.36%)
     

  • NIKKEI 225

    38,405.66
    +470.90 (+1.24%)
     

  • CAD/EUR

    0.6820
    -0.0004 (-0.06%)
     

TrendingWallStreet.com Shares Trend Research on GNK, SGLB, LBMH, and VNDA

ACCESSWIRE

Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.

Genco Shipping & Trading Ltd. (NYSE:GNK - News) shares closed down 8.50 percent on Monday with nearly 2 million shares traded. The stock traded in a range of 2.26 - 2.49 a share yesterday. In recent months the stock has retraced significantly, from a high of $4.98 on September 10th, to an intraday low of $2.26 yesterday. Genco Shipping & Trading Limited engages in the ocean transportation of dry bulk cargoes through the ownership and operation of drybulk carrier vessels worldwide.

Get more information on Genco Shipping & Trading Ltd. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/GNK

Sigma Labs, Inc. (OTC:SGLB - News) shares closed up 17.50 percent on Monday with about 17.4 million shares traded. The stock hit a new 52-week high of $0.24 in intra-day trading after the company announced that it has extended its contract with Honeywell Aerospace a division of Honeywell International (NYSE:HON - News) to include enhancements to further demonstrate the capabilities of Sigma Labs' PrintRite3D® technology. The contract extension is part of a Defense Advanced Research Project Agency (DARPA) project to develop an Integrated Computational Material Engineering (ICME) framework to accurately predict the material properties of components produced using Additive Manufacturing or 3D printing for metal parts.

ADVERTISEMENT

Get more information on Sigma Labs, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/SGLB

Liberator Medical Holdings, Inc. (OTCBB:LBMH - News) shares closed up 9.77 percent on Monday with almost 395,000 shares traded. The stock had a trading range of 2.15 to 2.48 with 2.48 becoming a new 52-week high for the stock. The Company announced that its common stock has been approved for listing on the NYSE MKT. The Company expects its common stock to begin trading on the NYSE MKT on November 20, 2013, trading under the existing symbol "LBMH." The Company's common stock will continue to be quoted on the Over-the-Counter Bulletin Board (the "OTCBB") under the symbol "LBMH" until the shares begin officially trading on the NYSE MKT, after which time the common stock will no longer be quoted on the OTCBB.

Get more information on Liberator Medical Holdings, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/LBMH

Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA - News) shares closed down 16.77 percent on Monday and traded in between 12.02 - 14.41 a share. The stock traded a little more than 4 million shares yesterday and was one of the biggest percentage droppers on the NASDAQ yesterday. Vanda Pharmaceuticals currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Get more information on Vanda Pharmaceuticals, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/VNDA

Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.